The impact of travel distance, travel time and waiting time on
health-related quality of life of diabetes patients: An
investigation in six European countries Journal Article
In: Diabetes Res Clin Pract, vol. 126, pp. 16–24, 2017.
@article{Konerding2017-yy,
title = {The impact of travel distance, travel time and waiting time on
health-related quality of life of diabetes patients: An
investigation in six European countries},
author = {Uwe Konerding and Tom Bowen and Sylvia G Elkhuizen and Raquel Faubel and Paul Forte and Eleftheria Karampli and Mahdi Mahdavi and Tomi Malmström and Elpida Pavi and Paulus Torkki},
year = {2017},
date = {2017-02-01},
journal = {Diabetes Res Clin Pract},
volume = {126},
pages = {16--24},
address = {Ireland},
abstract = {AIMS: The effects of travel distance and travel time to the
primary diabetes care provider and waiting time in the practice
on health-related quality of life (HRQoL) of patients with type 2
diabetes are investigated. RESEARCH DESIGN AND METHODS: Survey
data of 1313 persons with type 2 diabetes from six regions in
England (274), Finland (163), Germany (254), Greece (165), the
Netherlands (354), and Spain (103) were analyzed. Various
multiple linear regression analyses with four different EQ-5D-3L
indices (English, German, Dutch and Spanish index) as target
variables, with travel distance, travel time, and waiting time in
the practice as focal predictors and with control for study
region, patient's gender, patient's age, patient's education,
time since diagnosis, thoroughness of provider-patient
communication were computed. Interactions of regions with the
remaining five control variables and the three focal predictors
were also tested. RESULTS: There are no interactions of regions
with control variables or focal predictors. The indices decrease
with increasing travel time to the provider and increasing
waiting time in the provider's practice. CONCLUSIONS: HRQoL of
patients with type 2 diabetes might be improved by decreasing
travel time to the provider and waiting time in the provider's
practice.},
keywords = {EQ-5D; Health-related quality of life; Travel distance to provider; Travel time to provider; Type 2 diabetes mellitus; Waiting time in provider's practice},
pubstate = {published},
tppubtype = {article}
}
AIMS: The effects of travel distance and travel time to the
primary diabetes care provider and waiting time in the practice
on health-related quality of life (HRQoL) of patients with type 2
diabetes are investigated. RESEARCH DESIGN AND METHODS: Survey
data of 1313 persons with type 2 diabetes from six regions in
England (274), Finland (163), Germany (254), Greece (165), the
Netherlands (354), and Spain (103) were analyzed. Various
multiple linear regression analyses with four different EQ-5D-3L
indices (English, German, Dutch and Spanish index) as target
variables, with travel distance, travel time, and waiting time in
the practice as focal predictors and with control for study
region, patient's gender, patient's age, patient's education,
time since diagnosis, thoroughness of provider-patient
communication were computed. Interactions of regions with the
remaining five control variables and the three focal predictors
were also tested. RESULTS: There are no interactions of regions
with control variables or focal predictors. The indices decrease
with increasing travel time to the provider and increasing
waiting time in the provider's practice. CONCLUSIONS: HRQoL of
patients with type 2 diabetes might be improved by decreasing
travel time to the provider and waiting time in the provider's
practice.